1st Quarter - Report

PHILIPS HOLDING USA, INC. for PHILIPS HOLDING USA INC.

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$550,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report (this page) Apr 20, 2026 $550,000 Replaced
1st Quarter - Amendment Apr 23, 2026 $580,000 Replaced
1st Quarter - Amendment Jul 20, 2026 $660,000 Yes

What was lobbied

9 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

S. 1399, the Health Tech Investment Act (whole bill) and H.R. 6197, the Health Tech Investment Act (whole bill) Site neutrality payments under Medicare Medicare Physician Fee Schedule reform Extension of Medicare telehealth waivers - H.R. 5081/S. 2709 - The Telehealth Modernization Act (all sections) S. 1717, Ensuring Patient Access to Critical Breakthrough Products Act (whole bill) and H.R. 5343, Ensuring Patient Access to Critical Breakthrough Products Act (whole bill) H.R. 5343, Ensuring Patient Access to Critical Breakthrough Products Act - whole bill

Foreign entity interest: The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.

LobbyistCovered position, as disclosed
ELIZABETH PIKA SHARP —
MONICA VOLANTE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 5081 (119th), S. 1717 (119th), H.R. 5343 (119th), H.R. 6197 (119th), S. 1399 (119th), S. 2709 (119th)

Health Issues HCR

Third-party servicing of medical devices, right-to-repair of medical devices, remanufacturing of medical devices Cybersecurity of medical devices FDA regulation of Artificial Intelligence EPA ethylene oxide (EtO) regulations under FIFRA and NESHAP review - device sterilization Efforts to improve access to healthcare for underserved communities and activities to enhance maternal healthcare Sustainability in healthcare throughout the value chain including procurement, product development and design, and the benefits thereof

Foreign entity interest: The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.

LobbyistCovered position, as disclosed
ELIZABETH PIKA SHARP —
MONICA VOLANTE —

Contacted: Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Budget/Appropriations BUD

FY 2027 Veterans Affairs Appropriations, in general with some focus on telehealth provisions FY 2027 Defense Department Appropriations National Defense Authorization Act for Fiscal Year 2027, including issues related to RATE and low helium MRIs

Foreign entity interest: The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.

LobbyistCovered position, as disclosed
MATTHEW JOHN SHUMAN-TIMM —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA)

Veterans VET

U.S. Department of Veteran Affairs' acquisition process Telehealth for veterans Tele-critical care for Dept of Defense Nationwide expansion of tele-critical care program Digital Pathology RATE (Rapid Analysis of Threat Exposure)

Foreign entity interest: The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.

LobbyistCovered position, as disclosed
MATTHEW JOHN SHUMAN-TIMM —

Contacted: HOUSE OF REPRESENTATIVES; Veterans Affairs, Dept of (VA); SENATE

Defense DEF

FY2027 National Defense Authorization Act - Right to repair provisions Telehealth in DOD

Foreign entity interest: The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.

LobbyistCovered position, as disclosed
MATTHEW JOHN SHUMAN-TIMM —
MONICA VOLANTE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Chemicals/Chemical Industry CHM

EPA ethylene oxide (EtO) regulations under FIFRA and NESHAP review - device sterilization

Foreign entity interest: The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.

LobbyistCovered position, as disclosed
MONICA VOLANTE —

Contacted: HOUSE OF REPRESENTATIVES

Tariff (miscellaneous tariff bills) TAR

Tariff policy and the impact on patient access to medical devices Changes in U.S. Customs duties on imports, including negotiations on reciprocal tariffs with the EU and China.

Foreign entity interest: The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.

LobbyistCovered position, as disclosed
RICHARD PETER MERSKI —
ELIZABETH PIKA SHARP —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Council of Economic Advisers (CEA)

Taxation/Internal Revenue Code TAX

Changes in international tax provisions in H.R. 1, including section 899 and related BEAT provisions.

Foreign entity interest: The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.

LobbyistCovered position, as disclosed
RICHARD PETER MERSKI —
MONICA VOLANTE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1 (119th)

Homeland Security HOM

S. 2983, Protecting America from Cyberthreats Act, all provisions

Foreign entity interest: The interests of Philips Holdings USA Inc. are those of its parent corporation, Koninklijke Philips, N.V.

LobbyistCovered position, as disclosed
MONICA VOLANTE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 2983 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.